Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies

TO THE EDITOR: Drug-induced immune thrombocytopenia (DITP) is caused by drug-dependent platelet-reactive antibodies DDAbs) that induce platelet destruction when a drug is taken for which the antibody is specific.[1][1][⇓][2][⇓][3][⇓][4]-[5][5] The widely used cancer drug oxaliplatin is a